Reliability of Tricuspid Regurgitant Jet Velocity Measurements in Children and Young Adults with Sickle Cell Disease.

Blood ◽  
2009 ◽  
Vol 114 (22) ◽  
pp. 2581-2581
Author(s):  
Robert I. Liem ◽  
Stephanie A. Pelligra ◽  
Amy D. Shah ◽  
Richard J. Labotka ◽  
Luciana T. Young ◽  
...  

Abstract Abstract 2581 Poster Board II-558 Tricuspid regurgitant jet velocity (TRJV) measurements are used commonly for estimating pulmonary artery pressures among individuals with sickle cell disease (SCD) undergoing screening for pulmonary hypertension, defined by TRJV ≥ 2.5 m/sec. Measurements, however, may be prone to variability and have not been subjected to reliability testing in this population. The objective of our study was to examine reliability as well as potential sources of variability associated with TRJV measurements in a cohort of children and young adults with SCD. Methods We evaluated TRJV at steady state in a convenience sample of 30 subjects (53% male) with SCD (SS n=25, SC n=1, S-Beta0 thalassemia n=4) during 2 separate visits 1 week apart. In a blinded fashion, peak TRJV was independently measured by 2 experienced sonographers and officially interpreted by 2 readers who were attending cardiologists at standard time points in the protocol that permitted assessment of reliability and agreement. We calculated within subject variability as well as intra-/inter-sonographer and reader reliability in this analysis using Intraclass Correlation Coefficient (ICC) and Cohen's kappa to assess TRJV as a continuous and categorical variable, respectively. Agreement was also examined graphically using Bland-Altman plots. Results Sonographers were able to measure TRJV in all subjects (mean age, 15.8±3.3 years, range 10 to 22). Readers, however, designated tricuspid regurgitation unquantifiable in 13% of their final interpretations, most commonly due to an inadequate Doppler window. We found that intra-reader reliability was highest (ICC=0.93 [95% CI 0.86, 0.97], p<0.001) and within subject reliability lowest (ICC=0.36 [95% CI 0.02, 0.64], p=0.021) for single TRJV measurements. Inter-reader, intra-/inter-sonographer and between sonographer/reader reliability was in the moderate range, with ICCs that ranged from 0.54 to 0.68. Sonographers and readers also categorized their TRJV measurements and interpretations, respectively, as normal (<2.5 m/s), mild elevation (2.5–2.9 m/s), modest elevation (≥3.0 m/s) or unquantifiable. Using this classification schema, we found that agreement on categories paralleled that on TRJV as a continuous variable. Intra-reader agreement was highest (kappa=0.74 [95% CI 0.53, 0.95], p<0.001) and within subject lowest (kappa=0.14 [95% CI −0.17, 0.46], p=0.38) for TRJV classification, with kappa values ranging from 0.30 to 0.45 for all other combinations of sonographer and reader agreement testing. We plotted absolute differences in sonographer TRJV measurements or reader interpretations against the averages of each pair of values to construct our Bland-Altman graphs (Figure 1). Variability was graphically evident despite finding that only 3.6 to 8.7% of absolute differences fell beyond ±2 standard deviations of the mean difference. For intra- and inter-reader agreement, we observed that absolute differences in readings increased with higher mean TRJV readings. Conclusions In summary, quantification of tricuspid regurgitation as well as classification of TRJV values in children and young adults with SCD are affected by several potential sources of variability, including intra-/inter-sonographer and reader differences in measurement and interpretation. Despite using a single sonographer for its determination, within subject reliability in our analysis was especially poor, which may in part reflect sonographer ability to obtain Doppler windows adequate for accurate quantification of tricuspid regurgitation. Our findings underscore the need for methodological improvements that ensure the reliability of measurements used to diagnose TRJV elevation in this population. Multi-institutional reliability testing may also be required to establish the degree of variability that should be considered acceptable in clinical trials involving individuals with SCD and TRJV elevation. Disclosures: No relevant conflicts of interest to declare.

Blood ◽  
2006 ◽  
Vol 108 (11) ◽  
pp. 1211-1211
Author(s):  
Robert I. Liem ◽  
Nichele M. Willingham ◽  
Luciana T. Young ◽  
Alexis A. Thompson

Abstract Pulmonary hypertension (PHT) has emerged as a frequent cause of increased morbidity and mortality in adults with sickle cell disease (SCD). However, the incidence, prevalence and etiology of PHT in children with SCD are currently unknown. An elevated tricuspid regurgitant jet velocity (TRJV) ≥ 2.5 m/sec on Doppler echocardiogram (ECHO) in adults may predict PHT usually diagnosed by traditional cardiac catheterization. We hypothesized that routinely measuring TRJV in children and young adults with SCD was feasible and that TRJV correlated with degree of baseline hemolysis. Methods Using a standard protocol, we prospectively measured steady state TRJV in a convenience, cross-sectional sample of 43 patients (mean age 14.2±2.8 years, range 10 to 20) with hemoglobin (Hb) SS, SC or S-β0 thalassemia at our institution as part of a PHT screening initiative beginning December 2005. Patients on chronic transfusions were excluded. The relationship between TRJV and same day laboratory studies and clinical data obtained from patient charts was examined. Results TRJV was not measurable in 5 of 43 (12%) patients, due presumably to normal pulmonary artery systolic pressures. Neither right ventricular hypertrophy nor decreased septal wall motion, both suggestive of PHT, was present when TRJV could not be determined. In the remaining 38 studies in which TRJV could be quantified (mean 2.34 m/sec±0.44), TRJV was ≥ 2.5 m/sec in 13 patients. Using Pearson’s correlation coefficient, we found a significant correlation between TRJV and LDH (r=0.54, p=0.01), with higher TRJV associated with higher LDH. There were also significant, though more modest, positive correlations between TRJV and WBC (r=0.37, p=0.05) and reticulocyte count (r=0.40, p=0.05) and a significant negative correlation between TRJV and Hb (r= -0.46, p=0.01). Using t-test for independent samples, we found a significant difference in mean LDH (458 IU/L±192 vs. 338 IU/L±144, p=0.037), Hb (8.7 g/dL±1.3 vs. 10.2 g/dL±1.6, p=0.008) and reticulocyte count (17.3%±10.3 vs. 10.7%±6.9, p=0.027) between patients with TRJV ≥ 2.5 and &lt;2.5 m/sec. A difference approaching significance in total WBC (11.4 x103/μL±5.3 vs. 8.3 x103/μL ±3.2, p=0.075) was also observed between the two groups. We found neither a significant difference in mean values between the two groups nor significant relationships with TRJV when we examined platelet count, plasma free Hb, percent fetal Hb or total bilirubin. Using Fisher’s Exact Test, we did not demonstrate in our small cohort a difference in the proportion of patients with TRJV ≥ 2.5 or &lt; 2.5 m/sec who had a history of hydroxyurea use, acute chest syndrome, frequent pain, asthma, splenectomy, gallstones, priapism, exchange transfusion, heart disease or tonsilloadenoidectomy. Conclusions We conclude that TRJV by ECHO is quantifiable in most children and young adults being evaluated for PHT and that a higher LDH and reticulocyte count and a lower Hb at baseline are observed more frequently with elevated TRJV. Larger cohort studies are needed to test the predictive value of one or more of these markers of hemolysis. Although long term outcomes associated with elevated TRJV, as an indication of PHT, in children with SCD remains unclear, decreasing hemolysis in this population may represent an early therapeutic target in the prevention of future clinically significant PHT.


Thorax ◽  
2017 ◽  
Vol 73 (6) ◽  
pp. 575-577 ◽  
Author(s):  
Alan Lunt ◽  
Lucy Mortimer ◽  
David Rees ◽  
Sue Height ◽  
Swee Lay Thein ◽  
...  

To detect and characterise different phenotypes of respiratory disease in children and young adults with sickle cell disease (SCD), 11 lung function and haematological biomarkers were analysed using k-means cluster analysis in a cohort of 114 subjects with SCD aged between 5 and 27 years. Three clusters were detected: cluster 1 had elevated pulmonary capillary blood volume, mixed obstructive/restrictive lung disease, hypoxia and moderately severe anaemia; cluster 2 were older patients with restrictive lung disease; and cluster 3 were younger patients with obstructive lung disease, elevated serum lactate dehydrogenase and bronchodilator reversibility. These results may inform more personalised management strategies to improve outcomes.


2009 ◽  
Vol 52 (7) ◽  
pp. 842-846 ◽  
Author(s):  
Robert I. Liem ◽  
Luciana T. Young ◽  
Alexis A. Thompson

Author(s):  
Anna M. Hood ◽  
Allison A. King ◽  
Melanie E. Fields ◽  
Andria L. Ford ◽  
Kristin P. Guilliams ◽  
...  

2019 ◽  
Vol 66 (5) ◽  
pp. e27601
Author(s):  
Allistair A. Abraham ◽  
Haili Lang ◽  
Emily Riehm Meier ◽  
Robert S. Nickel ◽  
Marcus Dean ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document